Olivier Collard
Saint-etienne-de-valoux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Corrigendum to "Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)": [Ann Oncol 26 (2015) 2168-2173].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 16, 2025
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 05, 2025
Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma.
Journal: The New England journal of medicine
Published: September 04, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 19, 2024
Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: December 05, 2023
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial.
Journal: Nature communications
Published: February 24, 2023
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.
Journal: Anticancer research
Published: September 05, 2022
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.
Journal: The Lancet. Oncology
Published: April 29, 2022
Ketamine in chronic pain: A Delphi survey.
Journal: European journal of pain (London, England)
Published: August 17, 2021
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
Journal: Cancers
Published: June 06, 2021
Last Updated: 09/26/2026